Global Pharmaceuticals Cold Chain Logistics Market Overview:
The growing need for maintaining the cold chain integrity for pharmaceutical products and decreasing the distribution cost by creating a single source distribution channel is boosting the demand of the pharmaceutical cold chain logistics market in the forecasted period. A cold chain is a temperature-controlled supply chain. It typically involves constant refrigeration of the product from the time of its production through its transportation, handling, storage, and delivery. Some of the players profiled in the study are DHL International GmBH (Germany), KUEHNE + NAGEL (Switzerland), DB Schenker (Germany), United Parcel Service Inc. (United States), LifeConEx LLC (United States), World Courier (United States), FedEx Corporation (United States) and Agility (Kuwait).
On the basis of geography, the market of Pharmaceuticals Cold Chain Logistics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Drug Supply Stage, the sub-segment i.e. Outsourced will boost the Pharmaceuticals Cold Chain Logistics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Service, the sub-segment i.e. Transportation [Type (Sea freight, Airfreight, Overland, Integrated), Technique (Dry Ice, Liquid Nitrogen Gel Packs)] will boost the Pharmaceuticals Cold Chain Logistics market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- The Increasing Demand for Household Healthcare Products
- Growing Adoption for Fast Track Assistance
- Decreasing the Distribution Cost by Creating a Single Source Distribution Channel
- Growing Concern Related to High Packaging Cost
- Increasing Regulatory efforts Perticullerly around Temperature Management
- Rising Demand from the Emerging Markets
The industry is highly competitive. Major companies in the market strive to offer cloud-based supply chain solutions and secured supply chain functions as it helps manufacturers in verifying the authenticity of the drugs, in avoiding the production of counterfeit drugs and medical devices, among others. A large number of companies are entering into merger and acquisition to expand their geographical presence and proprietary knowledge. They are also focusing on reducing the overall packaging costs of their products. In addition, economic reforms have led to the growth of the global market.
Target Audience:Pharmaceutical Cold Chain Logistics Providers, Government Regulatory Bodies, Government Research Organizations, Private Research Organization and Others
Major Objectives Focused through this Study To define, describe, and forecast the Global Pharmaceuticals Cold Chain Logistics market on the basis of product [Airways, Roadways and Seaways] , application [BioPharma, ChemicalPharma and SpeciallyPharma], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Pharmaceuticals Cold Chain Logistics market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Pharmaceuticals Cold Chain Logistics industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Manufacturers which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Pharmaceuticals Cold Chain Logistics market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.